ARHGAP39 is a prognostic biomarker involved in immune infiltration in breast cancer
Abstract Background Current studies on the role of ARHGAP39 mainly focused on its effect on neurodevelopment. However, there are few studies on the comprehensive analysis of ARHGAP39 in breast cancer. Methods ARHGAP39 expression level was analyzed based on the Cancer Genome Atlas (TCGA), the Genotyp...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2023-05-01
|
| Series: | BMC Cancer |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12885-023-10904-4 |